Related Experiment Video
Updated: Jan 23, 2026
09:15
Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
Published on: May 11, 2020
6.4K
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation
Jamie Hartmann-Boyce1, Bosun Hong, Jonathan Livingstone-Banks
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, UK, OX2 6GG.
The Cochrane Database of Systematic Reviews
|June 6, 2019
Summary
Adding behavioral support to smoking cessation pharmacotherapy significantly increases quit rates. Increasing support intensity by 10-20% further boosts success, with benefits consistent across different medications and support levels.
Area of Science:
- Public Health
- Addiction Medicine
- Behavioral Science
Background:
- Pharmacotherapies are effective for smoking cessation.
- Behavioral support may further enhance quit rates.
Purpose of the Study:
- Evaluate the impact of adding or intensifying behavioral support for smokers using cessation medications.
- Assess if effects vary by pharmacotherapy type or support intensity.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials.
- Included participants using pharmacotherapy (NRT, bupropion, nortriptyline, varenicline).
- Compared outcomes based on amount and type of behavioral support.
Main Results:
- Behavioral support significantly increased smoking abstinence rates (RR 1.15, 95% CI 1.08 to 1.22).
- Increased support intensity yielded a 10-20% higher success rate.
- Benefits were consistent across pharmacotherapy types and baseline support levels.
Conclusions:
- High-certainty evidence supports behavioral support alongside pharmacotherapy for smoking cessation.
- Increasing behavioral support is likely to improve quit success.
- Further research is needed on specific behavioral intervention components.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
480
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
480
01:15Diabetes: Management and Pharmacotherapy
883
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
883
01:27Conjugate Addition (1,4-Addition) vs Direct Addition (1,2-Addition)
4.2K
α,β-Unsaturated carbonyl compounds with two electrophilic sites, the carbonyl carbon, and the β carbon, are susceptible to nucleophilic attack via two modes: conjugate or 1,4-addition and direct or 1,2-addition.
Conjugate addition results in a thermodynamically stable product. The reaction retains the stronger C=O bond at the expense of the weaker C=C π bond. The process is slow as the β carbon is less electrophilic than the carbonyl carbon.
Direct addition products are...
Conjugate addition results in a thermodynamically stable product. The reaction retains the stronger C=O bond at the expense of the weaker C=C π bond. The process is slow as the β carbon is less electrophilic than the carbonyl carbon.
Direct addition products are...
4.2K
01:22Heart Failure VI: Adjunct Therapies
280
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
280
01:28Self-Help Support Groups
339
Self-help support groups are voluntary, community-based organizations that provide a platform for individuals with shared concerns to exchange support, insights, and practical strategies for coping with life challenges. Typically led by group members or paraprofessionals, these groups form a cornerstone of mental health care, especially in reaching populations that are underserved by traditional healthcare systems.
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
339
01:08Conjugate Addition of Enolates: Michael Addition
3.4K
The attack of a nucleophile at the β carbon of an α,β-unsaturated carbonyl compound is called conjugate addition. Conjugate addition reactions of active methylene compounds, such as β-diketones, β-keto esters, β-keto nitriles, and α-nitro ketones, are called Michael addition reactions.
3.4K